VRXA offering history
Every offering-related filing in Veraxa Biotech AG - Post de-SPAC’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 55 filings back to Jul 31, 2025.
| Date | Filing | What it means | |
|---|---|---|---|
| Sep 4, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Sep 4, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 10, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 10, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 6, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 6, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 5, 2026 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Aug 5, 2026 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Jul 31, 2026 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
| Jul 31, 2026 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
| Feb 19, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 17, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
VRXA offering FAQ
When did VRXA last execute an offering?
Per SEC filings, Veraxa Biotech AG - Post de-SPAC's most recent priced offering document is a 424B5 filed 2026-08-10. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did VRXA last announce or register an offering?
The most recent registration is a F-1/A filed 2026-08-05. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.